Investigational drug · Phase 2
AV-001
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Acute Respiratory Distress Syndrome, Viral or Bacterial Infections, Pneumonia.
Phase 2Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
3
Any phase or sponsor naming "AV-001"
First trial start
2021
Dec 20, 2021
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "AV-001", any sponsor or status.
Conditions studied
As listed on its trial records.
- Acute Respiratory Distress Syndrome
- Viral or Bacterial Infections
- Pneumonia
- Pneumonia, Viral
- Respiratory Infection
- COVID-19 Acute Respiratory Distress Syndrome
Approved drugs for the same conditions: COVID-19 · Pneumonia · Infectious disease and vaccines · Rare and genetic disease
Largest trials
Live from ClinicalTrials.gov: studies naming "AV-001" as an intervention, largest first.
- Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.Active, not recruiting
Vasomune Therapeutics, Inc.Industry
NCT05123755 · 60 participants · Start Dec 20, 2021 · Primary completion Sep 2026
Drug: AV-001 Injection; AV-001 Placebo Injection · For: Acute Respiratory Distress Syndrome; Viral or Bacterial Infections; Pneumonia and 3 more
Sites: Newport Beach, California; Denver, Colorado; Chicago, Illinois · 6 sites in all
London Health Sciences Centre Research InstituteAcademic, hospital or other
NCT07234890 · 60 participants (planned) · Start Dec 16, 2025 · Primary completion Dec 31, 2027
Drug: AV-001 or Placebo Injection · For: Hemodialysis
Sites: London, Canada
Vasomune Therapeutics, Inc.Industry
NCT04737486 · 48 participants · Start Dec 16, 2020 · Primary completion Mar 10, 2021
Drug: AV-001 · For: Covid19-associated ARDS; Covid19; ARDS
Sites: Cincinnati, Ohio
Newest research
PubMed records naming it or its code names, newest first.
- Treatment of vascular dementia in female rats with AV-001, an Angiopoietin-1 mimetic peptide, improves cognitive function.
Gao H, Liu X, Venkat P, et al. · Front Neurosci 2024
- Early therapeutic effects of an Angiopoietin-1 mimetic peptide in middle-aged rats with vascular dementia.
Gao H, Findeis EL, Culmone L, et al. · Front Aging Neurosci 2023
- Treatment With an Angiopoietin-1 Mimetic Peptide Improves Cognitive Outcome in Rats With Vascular Dementia.
Culmone L, Powell B, Landschoot-Ward J, et al. · Front Cell Neurosci 2022
Also in development for Acute Respiratory Distress Syndrome
- STSA-1002Phase 32 trials
Staidson (Beijing) Biopharmaceuticals Co., Ltd · Acute Respiratory Distress Syndrome (ARDS), Acute Respiratory Distress Syndrome
- UC-MSCRY_SW01 cell, Human umbilical cord mesenchymal stem cellsPhase 28 trials
Jiangsu Renocell Biotech Company · Acute Respiratory Distress Syndrome, Lupus Nephritis, Spinocerebellar Ataxia Type 1
- AtibuclimabIC14Phase 24 trials
Implicit Bioscience · Acute Respiratory Distress Syndrome, Adult Respiratory Distress Syndrome, Acute Lung Injury
- SecretomeConditioned, Umbilical Cord Mesenchymal Stem Cells derived ConditionedPhase 24 trials
PT. Prodia Stem Cell Indonesia · Acute Respiratory Distress Syndrome, Androgenetic Alopecia, Ischemic Stroke
- paridiprubartPhase 22 trials
PPD Development, LP · Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)
- rhu-pGSNrecombinant human gelsolin, Recombinant human plasma gelsolin pre-exposurePhase 22 trials
BioAegis Therapeutics Inc. · Acute Respiratory Distress Syndrome, Infections, Decompression Sickness
- vilobelimabPhase 22 trials
PPD Development, LP · Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.